Evidence map›Paper›PMID 40246643›Full record

ArticleActa biomaterialia2025

Corrigendum to "Oxygen-generating microparticles downregulate HIF-1α expression, increase cardiac contractility, and mitigate ischemic injury" [Acta Biomaterialia, 2023, 159, 211-225].

Kalpana Mandal, Sivakoti Sangabathuni, Reihaneh Haghniaz, Satoru Kawakita, Marvin Mecwan, Aya Nakayama, Xuexiang Zhang, Masoud Edalati, Wei Huang, Ana Lopez Hernandez and 3 more

Abstract readPublished Erratum
In one paragraph

Article in Acta biomaterialia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Kalpana MandalTerasaki Institute for Biomedical Innovation, Los Angeles, California 90064, USA. Electronic address: kmandal@terasaki.org.
Sivakoti SangabathuniTerasaki Institute for Biomedical Innovation, Los Angeles, California 90064, USA; California NanoSystems Institute, University of California, Los Angeles, California 90095, USA.
Reihaneh HaghniazTerasaki Institute for Biomedical Innovation, Los Angeles, California 90064, USA; California NanoSystems Institute, University of California, Los Angeles, California 90095, USA; Department of Bioengineering, University of California, Los Angeles, California 90095, USA.
Satoru KawakitaTerasaki Institute for Biomedical Innovation, Los Angeles, California 90064, USA.
Marvin MecwanTerasaki Institute for Biomedical Innovation, Los Angeles, California 90064, USA.
Aya NakayamaTerasaki Institute for Biomedical Innovation, Los Angeles, California 90064, USA.
Xuexiang ZhangDepartment of Bioengineering, University of California, Los Angeles, California 90095, USA.
Masoud EdalatiTerasaki Institute for Biomedical Innovation, Los Angeles, California 90064, USA.
Wei HuangTerasaki Institute for Biomedical Innovation, Los Angeles, California 90064, USA.
Ana Lopez HernandezTerasaki Institute for Biomedical Innovation, Los Angeles, California 90064, USA.
Vadim JucaudTerasaki Institute for Biomedical Innovation, Los Angeles, California 90064, USA.
Mehmet R DokmeciTerasaki Institute for Biomedical Innovation, Los Angeles, California 90064, USA. Electronic address: mdokmeci@terasaki.org.
Ali KhademhosseiniTerasaki Institute for Biomedical Innovation, Los Angeles, California 90064, USA. Electronic address: khademh@terasaki.org.

Funding

Engineering personalized micro-tumor ecosystemsU01CA214411 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI KHADEMHOSSEINI, ALI, SENGUPTA, SHILADITYA · 2017 to 2021
$3.5M
Oxygen generating bioinks for 3D printed bone implantsR01AR074234 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI SHIN, SU RYON · 2018 to 2022
$1.9M
Research Supplements to Promote DiversityR01GM126571 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DOKMECI, MEHMET REMZI, YE, JING YONG · 2018 to 2021
$1.3M
NCI NIH HHS U01 CA214411NIAMS NIH HHS R01 AR074234NIGMS NIH HHS R01 GM126571
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40246643
PMCPMC12151463

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.